Patient-Centered Integration of Acupuncture to Decrease Pain for Cancer Survivors

Abramson Cancer Center at Penn Medicine1 site in 1 country36 target enrollmentMay 2014

ConditionsCancer Survivors

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cancer Survivors
Sponsor: Abramson Cancer Center at Penn Medicine
Enrollment: 36
Locations: 1
Primary Endpoint: Number of Adverse Events
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.

Registry

clinicaltrials.gov

Start Date

May 2014

End Date

January 2015

Last Updated

11 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Abramson Cancer Center at Penn Medicine

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Women or men age 18 years or older
•Primary diagnosis of cancer with history of stage I, II, or III cancer
•Finished primary cancer treatments (surgery, chemotherapy, radiotherapy)
•Have a Karnofsky score of 60 or greater
•Can understand written English
•Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week
•Have been taking pain medications daily
•Have had at least 15 days with pain in the preceding 30 days.

Exclusion Criteria

•Women or men with metastatic (stage IV) cancer
•Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks
•Planned surgical procedures in the next 12 weeks
•Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization
•Women who are pregnant or breastfeeding
•Unwillingness to adhere to study related procedures.